Velcan Holdings: Convening Notice of the Ordinary Annual General Meeting to be Held on June 25, 2025
PRESS RELEASE
Luxembourg, May 23, 2025
VELCAN HOLDINGS: CONVENING NOTICE OF THE ORDINARY ANNUAL GENERAL MEETING TO BE HELD ON JUNE 25, 2025
VELCAN HOLDINGS announces to the shareholders of the Company that the Ordinary Annual General Meeting will be held on Wednesday, June 25, 2025, at 11 a.m, in the offices of the law firm Tabery & Wauthier, 10 rue Pierre d'Aspelt, L‐1142 Luxembourg, in order to vote mainly on the approval of the 2024 condensed non-audited consolidated financial statements and of the 2024 audited statutory financial statements;
All required information and related documents will be available for downloading on the Company's website on May 23, 2025:
Convening notice of the Ordinary Annual General Meeting;
Board of Directors' report on the resolutions proposed to the General Meeting;
Text of the proposed resolutions;
Single participation form.
The annual management report and the audit report are available online since April 29, 2025.
The Board of Directors invites the shareholders to consult the following page:http://www.velcan.lu/investors/reports-accounts/
* * *
Investors Relations Contact investor@velcan.luVelcan Holdings is an investment holding company founded in 2005, managing a global portfolio of participations and investments.
The company was launched more than 15 years ago by its reference shareholder LHP SA, owned by Velcan Holdings' management team.
Velcan Holdings is listed on the unregulated Euro MTF Stock Market in Luxembourg (Ticker VLCN/ISIN FR0010245803). Velcan Holdings never performed any Public Offer as understood under Directive 2003/71/CE of the European Parliament and Council.This press release contains prospective information about the potential of the projects in progress and/or of the projects of which the development has begun. This information constitutes objectives attached to projects and shall not be construed as direct or indirect net income forecast of the concerned year. Reader's attention is also drawn on the fact that the performance of these objectives depends on future circumstances and that it could be affected and/or delayed by risks, known or unknown, uncertainties, and various factors of any nature, notably related to economic, commercial or regulatory conjuncture, which occurrence could be likely to have a negative impact on future activity and performances of the Group.
This announcement does not constitute a public offering ('offre au public') nor an invitation to the public or to any qualified investor in connection with any offering. This announcement is not an offer of securities in the United States of America or in any other jurisdiction/country.
Attachment
2025.05.23 AGO - Press Release
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
6 hours ago
- Yahoo
Turkey Blood Bags Market Competition, Forecast & Opportunities Report 2025, with Terumo BCT, Gazi Group, Lmb Technologie, Kizilay Biomedical, Ermed Tip Medikal, Erenler Medical, Kansuk Ilac & more
Turkey's Blood Bags Market sees growth through rising healthcare investments and demand spurred by chronic diseases and accidents. Opportunities lie in innovative, high-quality blood bags, tapping into urbanization and modern transfusion tech. Regulatory hurdles and competition remain challenges for market players. Turkish Blood Bags Market Dublin, June 05, 2025 (GLOBE NEWSWIRE) -- The "Turkey Blood Bags Market, By Region, Competition, Forecast & Opportunities, 2020-2030F" has been added to offering. Turkey's Blood Bags Market was valued at USD 28.25 Million in 2024 and is expected to reach USD 38.93 Million by 2030, rising at a CAGR of 5.45%. This growth is driven by a surge in demand for blood transfusions, spurred by increasing rates of chronic diseases, trauma cases, and expanding healthcare infrastructure. The market includes a wide range of blood bags such as collection, transfer, and multi-compartment bags, used extensively in hospitals, clinics, and blood banks. With healthcare investments on the rise in Turkey, including enhancements to blood donation networks and medical facilities, the demand for reliable, high-quality blood bags continues to grow. Factors such as urbanization, rising accident rates, and the adoption of modern transfusion technologies further fuel the market. However, challenges such as stringent regulatory requirements, supply chain disruptions, and competitive pressure remain significant. Market participants must innovate and comply with complex standards to capitalize on the increasing healthcare needs across the country. Key Market Drivers: Growing Number of Accidental Cases The increasing incidence of accidents in Turkey is a major factor boosting the demand for blood bags. In 2023, the country recorded a 19.2% rise in road traffic accidents involving injuries or fatalities compared to the previous year, resulting in a 25.2% increase in deaths and a 21.5% rise in injuries. This escalation directly correlates with the need for emergency transfusions, especially in trauma and emergency care units. Approximately 3 million patients in Turkey require blood transfusions annually, with 60.8% involving packed red blood cells, highlighting the critical role of blood bags. Urban centers like Istanbul, Ankara, and Izmir are particularly impacted due to high traffic density and industrial activity. As a result, there is sustained pressure on healthcare providers to maintain an adequate supply of sterile and functional blood bags, further driving market demand. Key Market Challenges: Regulatory and Compliance Barriers The Turkish blood bags market operates under stringent regulatory scrutiny to ensure product safety and efficacy in line with international standards. While these measures uphold quality, they also create significant barriers for manufacturers. Compliance involves obtaining local certifications, CE markings, and adherence to strict hygiene and anti-contamination protocols. These requirements can result in substantial costs and time delays, particularly for domestic manufacturers aiming to meet evolving regulatory benchmarks. The dynamic nature of compliance standards adds complexity to market entry and scalability. Companies are often compelled to invest heavily in research and development, regulatory affairs, and quality assurance systems, which increases operational expenditures and slows down time to market. Key Market Trends: Technological Advancements in Blood Bag Design and Functionality Innovations in blood bag design are reshaping the market by improving safety, efficiency, and usability. Advanced blood bags now feature integrated filters, RFID-enabled tracking systems, and enhanced anticoagulant solutions that extend shelf life and reduce contamination risks. The development of multi-compartment, single-use blood bags allows for better separation, storage, and transport of different blood components, a key requirement in modern transfusion therapy. Hospitals and blood banks are increasingly adopting these advanced systems to boost patient safety and streamline inventory management. Manufacturers focusing on high-performance, tech-integrated blood bag solutions are gaining a competitive edge, tapping into both domestic demand and export potential with premium product offerings. Key Market Players: Terumo BCT Turkey Gazi Group Lmb Technologie Kizilay Biomedical Ermed Tip Medikal ERENLER MEDIKAL SAN. TIC. LTD. STI. Kansuk Ilac InstaMed Medical Equipment Trading Key Attributes: Report Attribute Details No. of Pages 85 Forecast Period 2024 - 2030 Estimated Market Value (USD) in 2024 $28.25 Million Forecasted Market Value (USD) by 2030 $38.93 Million Compound Annual Growth Rate 5.4% Regions Covered Turkey Report Scope: In this report, the Turkey Blood Bags Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below: Turkey Blood Bags Market, By Product Type: Single Blood Bag Double Blood Bag Triple Blood Bag Quadruple Blood Bag Penta Blood Bag Turkey Blood Bags Market, By Type: Collection Bag Transfer Bag Turkey Blood Bags Market, By Volume: 100ml 150ml 250ml 300ml 350ml 400ml 450ml 500ml Turkey Blood Bags Market, By Material: PVC PET Others Turkey Blood Bags Market, By End User: Hospitals Clinics Ambulatory Surgical Center Blood Banks Others Turkey Blood Bags Market, By Region: Marmara Region Central Anatolia Eastern Anatolia Region South-Eastern Anatolia Region Aegean Region Mediterranean Region Black Sea Region For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Turkish Blood Bags Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
7 hours ago
- Yahoo
Nanox AI Bone Solution Receives CE Mark Certification
By Karen Roman Nano-X Imaging Ltd. (Nasdaq: NNOX) said its AI bone solution HealthOST has received CE mark certification which enables its commercialization across Europe. HealthOST examines CT scans to assess vertebral height loss and bone mineral density and helps identify disease risk, such as osteoporosis, before fractures occur, it stated. 'This CE mark for HealthOST represents a significant expansion of our AI capabilities in Europe,' said Erez Meltzer, Nanox CEO and acting Chairman. 'By integrating seamlessly into routine CT scans, HealthOST helps healthcare providers maximize their existing resources, while identifying patients who might otherwise fall through the cracks of traditional screening methods.' Contact: Exec Edge Editor@
Yahoo
9 hours ago
- Yahoo
Turkey Blood Bags Market Competition, Forecast & Opportunities Report 2025, with Terumo BCT, Gazi Group, Lmb Technologie, Kizilay Biomedical, Ermed Tip Medikal, Erenler Medical, Kansuk Ilac & more
Turkey's Blood Bags Market sees growth through rising healthcare investments and demand spurred by chronic diseases and accidents. Opportunities lie in innovative, high-quality blood bags, tapping into urbanization and modern transfusion tech. Regulatory hurdles and competition remain challenges for market players. Turkish Blood Bags Market Dublin, June 05, 2025 (GLOBE NEWSWIRE) -- The "Turkey Blood Bags Market, By Region, Competition, Forecast & Opportunities, 2020-2030F" has been added to offering. Turkey's Blood Bags Market was valued at USD 28.25 Million in 2024 and is expected to reach USD 38.93 Million by 2030, rising at a CAGR of 5.45%. This growth is driven by a surge in demand for blood transfusions, spurred by increasing rates of chronic diseases, trauma cases, and expanding healthcare infrastructure. The market includes a wide range of blood bags such as collection, transfer, and multi-compartment bags, used extensively in hospitals, clinics, and blood banks. With healthcare investments on the rise in Turkey, including enhancements to blood donation networks and medical facilities, the demand for reliable, high-quality blood bags continues to grow. Factors such as urbanization, rising accident rates, and the adoption of modern transfusion technologies further fuel the market. However, challenges such as stringent regulatory requirements, supply chain disruptions, and competitive pressure remain significant. Market participants must innovate and comply with complex standards to capitalize on the increasing healthcare needs across the country. Key Market Drivers: Growing Number of Accidental Cases The increasing incidence of accidents in Turkey is a major factor boosting the demand for blood bags. In 2023, the country recorded a 19.2% rise in road traffic accidents involving injuries or fatalities compared to the previous year, resulting in a 25.2% increase in deaths and a 21.5% rise in injuries. This escalation directly correlates with the need for emergency transfusions, especially in trauma and emergency care units. Approximately 3 million patients in Turkey require blood transfusions annually, with 60.8% involving packed red blood cells, highlighting the critical role of blood bags. Urban centers like Istanbul, Ankara, and Izmir are particularly impacted due to high traffic density and industrial activity. As a result, there is sustained pressure on healthcare providers to maintain an adequate supply of sterile and functional blood bags, further driving market demand. Key Market Challenges: Regulatory and Compliance Barriers The Turkish blood bags market operates under stringent regulatory scrutiny to ensure product safety and efficacy in line with international standards. While these measures uphold quality, they also create significant barriers for manufacturers. Compliance involves obtaining local certifications, CE markings, and adherence to strict hygiene and anti-contamination protocols. These requirements can result in substantial costs and time delays, particularly for domestic manufacturers aiming to meet evolving regulatory benchmarks. The dynamic nature of compliance standards adds complexity to market entry and scalability. Companies are often compelled to invest heavily in research and development, regulatory affairs, and quality assurance systems, which increases operational expenditures and slows down time to market. Key Market Trends: Technological Advancements in Blood Bag Design and Functionality Innovations in blood bag design are reshaping the market by improving safety, efficiency, and usability. Advanced blood bags now feature integrated filters, RFID-enabled tracking systems, and enhanced anticoagulant solutions that extend shelf life and reduce contamination risks. The development of multi-compartment, single-use blood bags allows for better separation, storage, and transport of different blood components, a key requirement in modern transfusion therapy. Hospitals and blood banks are increasingly adopting these advanced systems to boost patient safety and streamline inventory management. Manufacturers focusing on high-performance, tech-integrated blood bag solutions are gaining a competitive edge, tapping into both domestic demand and export potential with premium product offerings. Key Market Players: Terumo BCT Turkey Gazi Group Lmb Technologie Kizilay Biomedical Ermed Tip Medikal ERENLER MEDIKAL SAN. TIC. LTD. STI. Kansuk Ilac InstaMed Medical Equipment Trading Key Attributes: Report Attribute Details No. of Pages 85 Forecast Period 2024 - 2030 Estimated Market Value (USD) in 2024 $28.25 Million Forecasted Market Value (USD) by 2030 $38.93 Million Compound Annual Growth Rate 5.4% Regions Covered Turkey Report Scope: In this report, the Turkey Blood Bags Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below: Turkey Blood Bags Market, By Product Type: Single Blood Bag Double Blood Bag Triple Blood Bag Quadruple Blood Bag Penta Blood Bag Turkey Blood Bags Market, By Type: Collection Bag Transfer Bag Turkey Blood Bags Market, By Volume: 100ml 150ml 250ml 300ml 350ml 400ml 450ml 500ml Turkey Blood Bags Market, By Material: PVC PET Others Turkey Blood Bags Market, By End User: Hospitals Clinics Ambulatory Surgical Center Blood Banks Others Turkey Blood Bags Market, By Region: Marmara Region Central Anatolia Eastern Anatolia Region South-Eastern Anatolia Region Aegean Region Mediterranean Region Black Sea Region For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Turkish Blood Bags Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Sign in to access your portfolio
